Open Label Study Assessing Effectiveness Of Amlodipine/Atorvastatin In Subjects With Hypertension and Dyslipidaemia

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.1,250 enrolled

Overview

To evaluate the effectiveness of amlodipine/atorvastatin therapy by assessing the percentage of subjects who reach target blood pressure (BP) and LDL-C targets as defined by their governing guidelines.

Study Type

INTERVENTIONAL

Allocation

NON_RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

1,250

Conditions

Hypertension Dyslipidemia

Interventions

Amlodipine/AtorvastatinDRUG

Eligibility

Sex: ALLMin age: 18 YearsMax age: 80 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients who are above target LDL-C and BP who are eligible for treatment Exclusion Criteria: * High liver enzymes

Locations (126)

Outcomes

Primary Outcomes

To evaluate the number of patients who reach target blood pressure (BP) and

LDL-C targets as defined by their governing guidelines.

Secondary Outcomes

To assess changes from baseline to end of treatment for the following efficacy

parameters: LDL-C, total cholesterol (TC), triglycerides, high-density lipoprotein

cholesterol (HDL-C), HDL-C/LDL-C ratio, TC/HDL-C ratio. Systolic Blood Pressure

(SBP) and Diastolic Blood Pressue (DBP).

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

Pfizer Investigational Site

Calgary, Alberta, Canada

Pfizer Investigational Site

Calgary, Alberta, Canada

Pfizer Investigational Site

Calgary, Alberta, Canada

Pfizer Investigational Site

Calgary, Alberta, Canada

Pfizer Investigational Site

Calgary, Alberta, Canada

Pfizer Investigational Site

Red Deer, Alberta, Canada

Pfizer Investigational Site

Campbell River, British Columbia, Canada

Pfizer Investigational Site

Chilliwack, British Columbia, Canada

Pfizer Investigational Site

New Westminster, British Columbia, Canada

Pfizer Investigational Site

North Vancouver, British Columbia, Canada

...and 116 more locations